SCHEMBL18640269

SCHEMBL18640269

CCCCCN1CCC(N)CC1Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.51
▸ TACR1 P25103 1/20 0.45
▸ KMT2A Q03164 1/20 0.43
▸ SPHK1 Q9NYA1 1/20 0.42
▸ CCR3 P51677 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18640221 0.99 KCNH2 (0.53) KCNH2TACR1KMT2ASPHK1
SCHEMBL18640359 0.96 KCNH2 (0.46) KCNH2TACR1CCR3
SCHEMBL18640284 0.91 TACR1 (0.47) KCNH2TACR1
SCHEMBL11788316 0.84 KCNH2 (0.51) KCNH2KMT2ASPHK1CCR3
SCHEMBL18640256 0.82 TACR1 (0.47) TACR1CCR3
SCHEMBL18640337 0.82 OPRK1 (0.45) TACR1
SCHEMBL11404739 0.81 KCNH2 (0.56) KCNH2SPHK1
SCHEMBL8925928 0.80 TACR1 (0.50) TACR1CCR3
SCHEMBL3652328 0.80 TACR1 (0.50) TACR1CCR3
SCHEMBL8925926 0.80 TACR1 (0.50) TACR1CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3349743-A1 METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION St. Jude Children's Research Hospital (US) 2018-07-25 — — EP disclosed
WO-2017049295-A1 METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2017-03-23 — — WO disclosed
Send feedback